NCT00590096已完成不适用
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,380
研究概览
简要总结
I-123-MIBG is used to image patients with neuroblastoma, pheochromocytoma and other neural crest tumors
详细描述
Entry criteria--Histologically documented neuroblastoma or pheochromocytoma or strong suspicion of neuroblastoma or pheochromocytoma.
Exclusion criteria--Pregnancy Randomization--None Procedure--Patients will receive a dose of I-123-MIBG by intravenous injection. Images will obtained at 18-24 hours after administration of the drug and at 42-48 hours as needed. SSKI will be used to block thyroid uptake of free I-123-iodide
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
入排标准
- 年龄范围
- 2 Weeks 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically proven neuroblastoma or pheochromocytoma or strong suspicion of neuroblastoma or pheochromocytoma
排除标准
- •Pregnancy
研究者
相似试验
Unknown
3 期
123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsMedullary Thyroid CarcinomaNeuroblastomaCarcinoid TumorsPheochromocytomaParagangliomaNCT01373736Vancouver Coastal Health
已完成
3 期
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or NeuroblastomaPheochromocytomaNeuroblastomaNCT00126412GE Healthcare251
已完成
不适用
Feasibility of 123I-IBZM Scintigraphy (a D2 Agonist) in Patients With Pheochromocytoma (PHEO) and/or Paraganglioma (PGL) : Study PilotChromaffin-tissue Derived TumorsNCT00875407Assistance Publique Hopitaux De Marseille10
招募中
2 期
68Ga-DOTATATE Neuroblastoma Imaging PilotNeuroblastomaNCT04559217Centre de recherche du Centre hospitalier universitaire de Sherbrooke20
Available
不适用
131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use ProtocolNeuroblastomaNCT01370330Kieuhoa Vo